AB1349 BIOLOGIC AND TARGETED SYNTHETIC DRUGS MANAGEMENT IN RHEUMATOID ARTHRITIS AFTER IMPLEMENTATION OF A COMMUNITY OPTIMIZATION PROTOCOL | Publicación